Results of Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease

Esophagus DiseasesGastroesophageal Reflux Disease (GERD)

Novel Surgical Treatments for Gastroesophageal Reflux Disease: Systematic Review of Magnetic Sphincter Augmentation and Electric Stimulation Therapy

Gastroenterology Res.

Stanak M, Erdos J, Hawlik K, Birsan T

doi: 10.14740/gr1024w.

Gastroesophageal Reflux Disease (GERD)

Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial

Gastrointest Endosc.

Bell R, Lipham J, Louie B, Williams V, Luketich J, Hill M, Richards W, Dunst C, Lister D, McDowell-Jacobs L, Reardon P, Woods K, Gould J, Buckley FP 3rd, Kothari S, Khaitan L, Smith CD, Park A, Smith C, Jacobsen G, Abbas G, Katz P

doi: 10.1016/j.gie.2018.07.007.

Gastroesophageal Reflux Disease (GERD)

The Reflux Improvement and Monitoring (TRIM) Program Is Associated With Symptom Improvement and Weight Reduction for Patients With Obesity and Gastroesophageal Reflux Disease

Am J Gastroenterol.

Yadlapati R, Pandolfino JE, Alexeeva O, Gregory DL, Craven MR, Liebovitz D, Lichten A, Seger E, Workman M, St Peter N, Craft J, Doerfler B, Keswani RN

doi: 10.1038/ajg.2017.262.

Gastroesophageal Reflux Disease (GERD)

Surgical Management of Gastroesophageal Reflux Disease in Patients with Severe Esophageal Dysmotility

J Gastrointest Surg.

Armijo PR, Hennings D, Leon M, Pratap A, Wheeler A, Oleynikov D

doi: 10.1007/s11605-018-3968-6.

Gastroesophageal Reflux Disease (GERD)

Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders

Ann Gastroenterol.

de Bortoli N, Tolone S, Frazzoni M, Martinucci I, Sgherri G, Albano E, Ceccarelli L, Stasi C, Bellini M, Savarino V, Savarino EV, Marchi S

doi: 10.20524/aog.2018.0314.

Esophagus DiseasesGastroesophageal Reflux Disease (GERD)

Surgical management of gastroesophageal reflux disease in patients with systemic sclerosis

Surg Endosc.

Yan J, Strong AT, Sharma G, Gabbard S, Thota P, Rodriguez J, Kroh M

doi: 10.1007/

Gastroesophageal Reflux Disease (GERD)

Mucosal Impedance: a New Approach to Diagnosing Gastroesophageal Reflux Disease and Eosinophilic Esophagitis

Curr Gastroenterol Rep.

Barrett C, Choksi Y, Vaezi MF

doi: 10.1007/s11894-018-0639-4.

Gastroesophageal Reflux Disease (GERD)

First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease

World J Gastroenterol.

Liang CM, Kuo MT, Hsu PI, Kuo CH, Tai WC, Yang SC, Wu KL, Wang HM, Yao CC, Tsai CE, Wang YK, Wang JW, Huang CF, Wu DC, Chuah SK; Taiwan Acid-Related Disease Study Group

doi: 10.3748/

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Impact of concomitant dyspepsia and irritable bowel syndrome on symptom burden in patients with gastroesophageal reflux disease

J Formos Med Assoc.

Lei WY, Chang WC, Wen SH, Wong MW, Hung JS, Yi CH, Liu TT, Hsu CS, Orr WC, Vaezi MF, Pace F, Hsieh TC, Chen CL

doi: 10.1016/j.jfma.2018.12.00

Related content

Novel Surgical Treatments for Gastroesophageal Reflux Disease: Systematic Review of Magnetic Sphincter Augmentation and Electric Stimulation Therapy

Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial

The Reflux Improvement and Monitoring (TRIM) Program Is Associated With Symptom Improvement and Weight Reduction for Patients With Obesity and Gastroesophageal Reflux Disease

Surgical Management of Gastroesophageal Reflux Disease in Patients with Severe Esophageal Dysmotility

Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders

Surgical management of gastroesophageal reflux disease in patients with systemic sclerosis

Mucosal Impedance: a New Approach to Diagnosing Gastroesophageal Reflux Disease and Eosinophilic Esophagitis

First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease

Impact of concomitant dyspepsia and irritable bowel syndrome on symptom burden in patients with gastroesophageal reflux disease